The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some ...

This month, the administration announced new, reduced prices for 10 drugs in the program following negotiations between the federal government and drugmakers. The lower costs take effect in 2026.

marking the seventh loss in the legal battle by drugmakers and their allies. Although the drug manufacturers have repeatedly said that price negotiations will hurt their businesses and reduce ...

The negotiated price cuts won’t take effect until 2026, but a $2,000 annual cap on out-of-pocket prescription drug costs ...

Currently, health plan sponsors contracted by Medicare to administer coverage of drugs under the program’s Part D benefit negotiate rebates from drugmakers, resulting in non-public net prices.

The government says it has "negotiated" with drugmakers to arrive at these new prices. But the process wasn't a negotiation. The federal government is simply dictating prices, which will have ...

A federal change that allows Medicare to negotiate prices of 10 drugs is a positive step, but the American consumer is still ...

the Centers for Medicare and Medicaid Services have the ability to negotiate directly with pharmaceutical companies for the price of medications — and impose punitive taxes if the drugmakers ...

Medicare and drugmakers have completed negotiations to cut drug prices for 10 of Medicare's most common and most expensive drugs starting in 2026. Some medications help manage diabetes ...

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly ...

The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some ...